274 related articles for article (PubMed ID: 10793066)
1. Complement activation after oxidative stress: role of the lectin complement pathway.
Collard CD; Väkevä A; Morrissey MA; Agah A; Rollins SA; Reenstra WR; Buras JA; Meri S; Stahl GL
Am J Pathol; 2000 May; 156(5):1549-56. PubMed ID: 10793066
[TBL] [Abstract][Full Text] [Related]
2. Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1.
Collard CD; Montalto MC; Reenstra WR; Buras JA; Stahl GL
Am J Pathol; 2001 Sep; 159(3):1045-54. PubMed ID: 11549596
[TBL] [Abstract][Full Text] [Related]
3. A keratin peptide inhibits mannose-binding lectin.
Montalto MC; Collard CD; Buras JA; Reenstra WR; McClaine R; Gies DR; Rother RP; Stahl GL
J Immunol; 2001 Mar; 166(6):4148-53. PubMed ID: 11238665
[TBL] [Abstract][Full Text] [Related]
4. C-type lectins and galectins mediate innate and adaptive immune functions: their roles in the complement activation pathway.
Vasta GR; Quesenberry M; Ahmed H; O'Leary N
Dev Comp Immunol; 1999; 23(4-5):401-20. PubMed ID: 10426431
[TBL] [Abstract][Full Text] [Related]
5. Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation.
Lekowski R; Collard CD; Reenstra WR; Stahl GL
Protein Sci; 2001 Feb; 10(2):277-84. PubMed ID: 11266613
[TBL] [Abstract][Full Text] [Related]
6. Complement activation following reoxygenation of hypoxic human endothelial cells: role of intracellular reactive oxygen species, NF-kappaB and new protein synthesis.
Collard CD; Agah A; Stahl GL
Immunopharmacology; 1998 Mar; 39(1):39-50. PubMed ID: 9667422
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury.
Jordan JE; Montalto MC; Stahl GL
Circulation; 2001 Sep; 104(12):1413-8. PubMed ID: 11560858
[TBL] [Abstract][Full Text] [Related]
8. Human IgA activates the complement system via the mannan-binding lectin pathway.
Roos A; Bouwman LH; van Gijlswijk-Janssen DJ; Faber-Krol MC; Stahl GL; Daha MR
J Immunol; 2001 Sep; 167(5):2861-8. PubMed ID: 11509633
[TBL] [Abstract][Full Text] [Related]
9. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
[TBL] [Abstract][Full Text] [Related]
10. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury.
de Vries B; Walter SJ; Peutz-Kootstra CJ; Wolfs TG; van Heurn LW; Buurman WA
Am J Pathol; 2004 Nov; 165(5):1677-88. PubMed ID: 15509537
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus.
Neth O; Jack DL; Johnson M; Klein NJ; Turner MW
J Immunol; 2002 Oct; 169(8):4430-6. PubMed ID: 12370377
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
13. Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy.
Endo M; Ohi H; Satomura A; Hidaka M; Ohsawa I; Fujita T; Kanmatsuse K; Matsushita M; Fujita T
Clin Nephrol; 2001 Mar; 55(3):185-91. PubMed ID: 11316237
[TBL] [Abstract][Full Text] [Related]
14. Mannose-binding lectin has a direct deleterious effect on ischemic brain microvascular endothelial cells.
Neglia L; Fumagalli S; Orsini F; Zanetti A; Perego C; De Simoni MG
J Cereb Blood Flow Metab; 2020 Aug; 40(8):1608-1620. PubMed ID: 31495300
[TBL] [Abstract][Full Text] [Related]
15. Mannan-binding lectin mediates renal ischemia/reperfusion injury independent of complement activation.
van der Pol P; Schlagwein N; van Gijlswijk DJ; Berger SP; Roos A; Bajema IM; de Boer HC; de Fijter JW; Stahl GL; Daha MR; van Kooten C
Am J Transplant; 2012 Apr; 12(4):877-87. PubMed ID: 22225993
[TBL] [Abstract][Full Text] [Related]
16. Identification of human mannose binding lectin (MBL) recognition sites for novel inhibitory antibodies.
Zhao H; Wakamiya N; Suzuki Y; Hamonko MT; Stahl GL
Hybrid Hybridomics; 2002 Feb; 21(1):25-36. PubMed ID: 11991814
[TBL] [Abstract][Full Text] [Related]
17. An assay for the mannan-binding lectin pathway of complement activation.
Petersen SV; Thiel S; Jensen L; Steffensen R; Jensenius JC
J Immunol Methods; 2001 Nov; 257(1-2):107-16. PubMed ID: 11687244
[TBL] [Abstract][Full Text] [Related]
18. Ficolins and the lectin complement pathway.
Matsushita M; Fujita T
Immunol Rev; 2001 Apr; 180():78-85. PubMed ID: 11414366
[TBL] [Abstract][Full Text] [Related]
19. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
Inoshita H; Matsushita M; Koide S; Kusaba G; Ishii M; Onda K; Gi MJ; Nakata M; Ohsawa I; Horikoshi S; Ohi H; Tomino Y
J Immunol Methods; 2009 Sep; 349(1-2):9-17. PubMed ID: 19699205
[TBL] [Abstract][Full Text] [Related]
20. Activation of the lectin pathway of complement in pig-to-human xenotransplantation models.
Bongoni AK; Kiermeir D; Jenni H; Wünsch A; Bähr A; Ayares D; Seebach JD; Wolf E; Klymiuk N; Constantinescu MA; Vögelin E; Rieben R
Transplantation; 2013 Nov; 96(9):791-9. PubMed ID: 23958924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
